| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,025 |
14,390 |
$2.50M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,028 |
4,774 |
$833K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,947 |
4,345 |
$726K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,970 |
4,069 |
$520K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,403 |
2,485 |
$356K |
| 71045 |
Radiologic examination, chest; single view |
1,998 |
1,572 |
$231K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,154 |
3,185 |
$226K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,483 |
1,317 |
$193K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
918 |
865 |
$125K |
| 90837 |
Psychotherapy, 53 minutes with patient |
958 |
493 |
$119K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,140 |
2,764 |
$84K |
| 71046 |
Radiologic examination, chest; 2 views |
861 |
707 |
$84K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,026 |
957 |
$80K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
448 |
208 |
$68K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,024 |
10,983 |
$61K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
373 |
365 |
$52K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
11,649 |
9,036 |
$50K |
| 90834 |
Psychotherapy, 45 minutes with patient |
302 |
181 |
$36K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
493 |
395 |
$34K |
| 87400 |
|
3,614 |
1,881 |
$31K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
808 |
657 |
$30K |
| 36415 |
Collection of venous blood by venipuncture |
13,371 |
10,016 |
$28K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,796 |
1,154 |
$24K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
900 |
823 |
$22K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
184 |
39 |
$21K |
| 84484 |
|
2,956 |
1,704 |
$17K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
556 |
420 |
$16K |
| 70450 |
Computed tomography, head or brain; without contrast material |
174 |
143 |
$15K |
| 80053 |
Comprehensive metabolic panel |
2,304 |
1,862 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
298 |
249 |
$12K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
84 |
75 |
$9K |
| 81001 |
|
4,248 |
3,481 |
$8K |
| 83690 |
|
2,047 |
1,653 |
$7K |
| 92567 |
|
188 |
170 |
$7K |
| 80076 |
|
1,649 |
1,348 |
$6K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
70 |
65 |
$6K |
| 95117 |
|
50 |
12 |
$5K |
| 92557 |
|
37 |
36 |
$5K |
| 83735 |
|
1,069 |
856 |
$4K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
72 |
67 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
100 |
79 |
$3K |
| 84703 |
|
554 |
477 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
225 |
205 |
$2K |
| 80305 |
|
283 |
217 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
137 |
105 |
$2K |
| 80320 |
|
35 |
29 |
$2K |
| 80061 |
Lipid panel |
344 |
298 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
60 |
51 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
59 |
50 |
$2K |
| 85027 |
|
304 |
249 |
$1K |
| 81003 |
|
767 |
629 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
159 |
132 |
$796.76 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
170 |
147 |
$710.37 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
67 |
64 |
$651.20 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
17 |
15 |
$624.62 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
72 |
52 |
$607.89 |
| 86592 |
|
148 |
135 |
$508.37 |
| 88142 |
|
29 |
26 |
$399.50 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
12 |
$288.96 |
| 87040 |
|
74 |
24 |
$240.72 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
15 |
13 |
$175.65 |
| 86803 |
|
13 |
12 |
$171.24 |
| 82800 |
|
56 |
43 |
$138.71 |
| 83605 |
|
93 |
42 |
$132.59 |
| J3490 |
Unclassified drugs |
254 |
165 |
$116.67 |
| 84146 |
|
38 |
36 |
$77.52 |
| 84481 |
|
39 |
37 |
$67.76 |
| 82607 |
|
39 |
37 |
$60.32 |
| 82553 |
|
66 |
39 |
$58.78 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
142 |
87 |
$49.00 |
| 82550 |
|
81 |
51 |
$44.43 |
| 85379 |
|
15 |
12 |
$36.54 |
| 84439 |
|
39 |
37 |
$36.08 |
| 82728 |
|
28 |
24 |
$27.26 |
| 82248 |
|
38 |
36 |
$20.08 |
| 83550 |
|
26 |
24 |
$17.48 |
| 83540 |
|
27 |
24 |
$12.94 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,012 |
627 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
127 |
99 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
224 |
125 |
$0.00 |
| A9270 |
Non-covered item or service |
70 |
50 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
131 |
53 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
32 |
14 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
18 |
15 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
223 |
163 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
77 |
68 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
17 |
13 |
$0.00 |